Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
10.34
+0.18 (1.77%)
At close: Dec 5, 2025, 4:00 PM EST
10.32
-0.02 (-0.19%)
After-hours: Dec 5, 2025, 5:01 PM EST
Entrada Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -103.46 | 65.63 | -6.69 | -94.62 | -51.16 | -26.52 | |
| Depreciation & Amortization | 4.2 | 3.77 | 2.84 | 1.9 | 1.12 | 0.33 | |
| Loss (Gain) From Sale of Assets | - | - | - | - | 0.07 | 0.02 | |
| Loss (Gain) From Sale of Investments | -5.55 | -10.02 | -5.78 | 0.15 | - | - | |
| Stock-Based Compensation | 19.95 | 17.92 | 13.11 | 9.9 | 2.53 | 0.33 | |
| Change in Accounts Receivable | 1.41 | 2.2 | -5.88 | - | - | - | |
| Change in Accounts Payable | 1.92 | 0.99 | -2.81 | 5.29 | -0.72 | 0.63 | |
| Change in Unearned Revenue | -53.42 | -119.81 | 139.98 | - | - | - | |
| Change in Income Taxes | -1.63 | -3.36 | 4.02 | - | - | - | |
| Change in Other Net Operating Assets | 8.65 | 1.12 | 1 | -16.4 | -2.71 | -0.35 | |
| Operating Cash Flow | -127.91 | -41.56 | 139.8 | -93.79 | -50.86 | -25.57 | |
| Capital Expenditures | -1.88 | -3.16 | -5.61 | -2.89 | -4.58 | -2.32 | |
| Investment in Securities | 142.94 | -24.64 | -132.78 | -145.76 | - | - | |
| Investing Cash Flow | 141.05 | -27.8 | -138.4 | -148.65 | -4.58 | -2.32 | |
| Issuance of Common Stock | 2.1 | 102.96 | 21.04 | 0.48 | 191.63 | 0.25 | |
| Financing Cash Flow | 2.1 | 102.96 | 21.04 | 0.48 | 307.46 | 50.09 | |
| Net Cash Flow | 15.24 | 33.61 | 22.45 | -241.96 | 252.02 | 22.2 | |
| Free Cash Flow | -129.8 | -44.72 | 134.19 | -96.67 | -55.44 | -27.89 | |
| Free Cash Flow Margin | -210.98% | -21.21% | 104.01% | - | - | - | |
| Free Cash Flow Per Share | -3.15 | -1.15 | 4.06 | -3.09 | -8.85 | -25.23 | |
| Cash Income Tax Paid | 4.62 | 4.62 | 14.72 | - | - | - | |
| Levered Free Cash Flow | -92.33 | -73.29 | 149.04 | -58.56 | -36.26 | -17.21 | |
| Unlevered Free Cash Flow | -92.33 | -73.29 | 149.04 | -58.56 | -36.26 | -17.21 | |
| Change in Working Capital | -43.07 | -118.85 | 136.32 | -11.11 | -3.42 | 0.28 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.